Inhibition of human herpes simplex virus type 2 by interferon γ and tumor necrosis factor α is mediated by indoleamine 2,3-dioxygenase

This publication has 40 references indexed in Scilit:

• Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic Cells
  The Journal of Experimental Medicine, 2002
• Potential Role of Human Brain Microvascular Endothelial Cells in the Pathogenesis of Brain Abscess: Inhibition of Staphylococcus aureus by Activation of Indoleamine 2,3-Dioxygenase
  Neuropediatrics, 2001
• Presence of herpes simplex virus (HSV) in peripheral leukocytes of patient who developed active HSV infection after bone marrow transplantation
  Journal of Clinical Virology, 2000
• Interferon‐γ‐Induced Activation of Indoleamine 2,3‐Dioxygenase in Cord Blood Monocyte‐Derived Macrophages Inhibits the Growth of Group B Streptococci
  The Journal of Infectious Diseases, 1998
• Management of herpes simplex virus type 1 pneumonia following liver transplantation
  Infection, 1996
• Viral Infections in Leukemia and Bone Marrow Transplant Patients
  Leukemia & Lymphoma, 1993
• Herpes Virus Infections in Immunocompromised Patients: Problems and Therapeutic Interventions
  Annals of Medicine, 1993
• Changing Presentation of Herpes Simplex Virus Infection in Neonates
  The Journal of Infectious Diseases, 1988
• Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
  The Journal of Experimental Medicine, 1985
• Diagnosis and Treatment of Herpes Simplex Encephalitis
  Annual Review of Medicine, 1981